11 contacts

Antoine Briens

Finance Analyst, DEBIOPHARM S.A.

Lausanne - Switzerland

 HomeUnited StatesAntoine Briens

  English   |   French

Schools attended

Lycée Henri Bergson (Classe préparatoire HEC)

Since 2007: DEBIOPHARM S.A.

Controlling Manager
Now, I am reponsible for the Controlling service and I manage another financial analyst.
I am currently implementing Cognos Planning to run the financial budgets.
This is a very interesting experience as "project manager".
This will allow the budget process to be more efficient, more secure and we will be able to provide more added-value to decision-makers.
I am also a privileged contact concerning financial matters for (Pharmaceutical) Project managers and Business managers : sustain change management, build forecasts, add calculations, etc.

About Debiopharm:
Debiopharm, based in Lausanne, Switzerland, is a privately owned company founded in 1979, specializing in ethical drug development and registration. The drug development expertise covers the formulation, manufacturing, pre-clinical and clinical stages up to marketing authorization, both in the USA and in Europe. Main products are oncology blockbusters such as Eloxatine and Decapeptyl.
Sector: Biotech

Since 2004: DEBIOPHARM S.A.

Finance Analyst
My role as a Financial Analyst:
First, I settled all the elements of an efficient Controlling system (yearly and revised budgets, monthly & on-line reporting, specific analyses, treasury forecasts) provided by the new accounting software (Pro-Concept ERP). This required to understand the business, clean and organize the data, create SQL requests and reports through the ERP and Excel.
In the same time, I had to explain to all users the new concepts, procedures and tools, and keep an attentive listening to manager needs.

About Debiopharm:
Debiopharm, based in Lausanne, Switzerland, is a privately owned company founded in 1979, specializing in ethical drug development and registration. The drug development expertise covers the formulation, manufacturing, pre-clinical and clinical stages up to marketing authorization, both in the USA and in Europe. Main products are oncology blockbusters such as Eloxatine and Decapeptyl.
Sector: Biotech

To access Antoine Briens's full profile
Registrer on Viadeo free


I am already a member of Viadeo